ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections.
about
On and Under the Skin: Emerging Basidiomycetous Yeast Infections Caused by Trichosporon SpeciesFungi on the skin: dermatophytes and MalasseziaAntifungal Activity and Action Mechanism of Histatin 5-Halocidin Hybrid Peptides against Candida sspInvasive Trichosporon Infection: a Systematic Review on a Re-emerging Fungal PathogenMalassezia infections in humans and animals: pathophysiology, detection, and treatmentIn Vitro Interactions between Non-Steroidal Anti-Inflammatory Drugs and Antifungal Agents against Planktonic and Biofilm Forms of Trichosporon asahiiIn Vitro Antifungal Activity of Sertraline and Synergistic Effects in Combination with Antifungal Drugs against Planktonic Forms and Biofilms of Clinical Trichosporon asahii IsolatesA cluster of Geotrichum clavatum (Saprochaete clavata) infection in haematological patients: a first Italian report and review of literature.Fungemia due to rare opportunistic yeasts: data from a population-based surveillance in Spain.Disseminated Cutaneous Trichosporonosis in an Adult Bone Marrow Transplant PatientIn vitro amphotericin B susceptibility of Malassezia pachydermatis determined by the CLSI broth microdilution method and Etest using lipid-enriched media.Molecular and nonmolecular diagnostic methods for invasive fungal infections.Malassezia yeasts: how many species infect humans and animals?Rhodotorula mucilaginosa associacted meningitis: A subacute entity with high mortality. Case report and review.Use of combination therapy to successfully treat breakthrough Trichosporon asahii infection in an acute leukemia patient receiving voriconazoleThe production of reactive oxygen species is a universal action mechanism of Amphotericin B against pathogenic yeasts and contributes to the fungicidal effect of this drug.Species distribution and susceptibility profile to fluconazole, voriconazole and MXP-4509 of 551 clinical yeast isolates from a Romanian multi-centre study.Pseudozyma aphidis fungemia after abdominal surgery: First adult caseKodameae ohmeri - An Emerging Yeast: Two Cases and Literature Review.Diagnosis of Invasive Fungal Diseases in Hematological Malignancies: A Critical Review of Evidence and Turkish Expert Opinion (TEO-2)Antifungal susceptibility profiles of bloodstream yeast isolates by Sensititre YeastOne over nine years at a large Italian teaching hospital.Misidentification of a Rare Species, Cryptococcus laurentii, by Commonly Used Commercial Biochemical Methods and Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry Systems: Challenges for Clinical Mycology Laboratories.Trichosporon faecale invasive infection in a patient with severe aplastic anemia: Efficacy of voriconazole and liposomal amphotericin B before neutrophil recovery.Emerging pan-resistance in Trichosporon species: a case report.Two Case Presentations Infected by Trichosporon asahii and Treated with Voriconazole Successfully.Epidemiology and Outcome of Trichosporon Fungemia: A Review of 185 Reported Cases From 1975 to 2014.Retrospective Analysis on the Use of Amphotericin B Lipid Complex in Neutropenic Cancer Patients with Suspected Fungal Infections in Lebanon, a Single Center Experience and Review of International Guidelines.Pseudozyma aphidis fungaemia with invasive fungal pneumonia in a patient with acute myeloid leukaemia: case report and literature reviewRhodotorula keratitis: a rarely encountered ocular pathogen.Trichosporon asahii infection presenting as chronic meningo-ventriculitis and intra ventricular fungal ball: a case report and literature review.Hospital use of systemic antifungal drugs: a multi-center surveillance update from Germany.FungiScope™ -Global Emerging Fungal Infection Registry.Cryptococcosis in HIV-negative Patients with Renal Dialysis: A Retrospective Analysis of Pooled CasesTrichosporonosis in Pediatric Patients With a Hematologic Disorder.Critical review of current clinical practice guidelines for antifungal therapy in paediatric haematology and oncology.Diagnostic of Fungal Infections Related to Biofilms.Predisposing factors and outcome of uncommon yeast species-related fungaemia based on an exhaustive surveillance programme (2002-14).Granulocyte transfusions in the management of invasive fungal infections.In Vitro Interactions of Echinocandins with Triazoles Against Multidrug-Resistant Candida auris.Pseudozyma and other non-Candida opportunistic yeast bloodstream infections in a large stem cell transplant center.
P2860
Q26801428-EC57F17E-B247-43EC-9E7F-0D6EBB6DEB57Q26995488-887C575B-692A-4ADE-85A7-7C833E8A5F81Q27320076-9F6E0C9E-4EB1-4057-8B9E-770F6247101EQ28071847-23FD3799-B61B-499F-A4CA-34807AB07181Q28088616-859217A9-CD31-48B5-86AB-B677A0C70217Q28550113-684A8597-D375-4144-A053-7791DC3E23CEQ28554839-7B94CCF1-4528-4E51-A35D-45F03DB0E4D3Q30251621-B7594360-D53C-4C98-B043-454F5BCA1C1AQ31119810-23041D2E-52A8-4144-B485-BD96B8107232Q33735765-3A7CD9DA-A55A-462D-A9CB-7F879D550065Q33798294-C3840A33-895E-4D2A-9664-338ED2057C2CQ34057660-E29EF373-CCF7-43E6-B91C-399D431438F6Q34407780-39F26A95-316B-4805-8AF6-6D2075259502Q34436538-7574C3D6-DB4B-45D9-BE4C-C1D12FC29B75Q34470045-A203ED01-D5FB-428C-A134-7F2E3D69403DQ34596780-3D0BD6B8-A192-40FA-94BD-56B2A015F649Q35254046-4D9A942F-58D8-4168-8FD9-C8595CBA2DC8Q35311276-C6BE10B7-D2B4-454C-BF41-40DE60136723Q35548464-8CF68FEF-1FB6-419F-A202-E4BFAAB431C1Q35678921-449CB7F6-FE0F-45CD-88B6-69CC53B8F7F9Q35746090-2CCA75AF-957D-49D7-A10A-910051AC8500Q35839167-E7BDEE88-5E60-445C-9023-38C022ED2233Q35864951-598FD68B-D581-4819-92D0-6F211A8F4979Q35988869-377280FA-F0F6-4B31-B0C0-FEA077FF12A1Q35999226-0E95402A-DD4C-4EC8-A68C-4EF74400E648Q36241645-674B80B6-C1E8-4EE0-821B-0D298706E321Q36427453-67B7A0A2-FC35-4464-9A61-E60ADCB85CB2Q36536763-5C8E7EEA-94CF-4048-A4C6-E3283EA8D193Q38269485-B3B3116E-BED5-44BE-84EE-9FFB7A84862AQ38318916-DC70BE41-91F6-437C-A3D5-EA986AFB5FACQ38357784-4345F677-1CCF-4750-B800-64526BF65498Q38668606-DAC45681-6455-4375-8736-8EEA9C0E309BQ38699194-03074E09-9FF0-4E71-941D-57AC55DCB402Q38782786-D549288F-03CE-4052-A131-498E4522080AQ38822532-4993BA0C-22AB-42E7-A9B9-15F87AD0DF6BQ38853348-F68A16F5-3A4B-4C75-AAF2-3488B59EC67EQ38883793-1B764861-FBE4-4B24-AA30-9E038900373CQ38907111-A96E89B5-15F7-4EBE-B720-5D045764DE56Q39092177-EF922CA0-EF2D-4C19-AA59-CADA520BD7DBQ39093853-86EBAFB6-228F-4859-9F51-9D18EA901CD6
P2860
ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
ESCMID and ECMM joint clinical ...... are invasive yeast infections.
@ast
ESCMID and ECMM joint clinical ...... are invasive yeast infections.
@en
ESCMID and ECMM joint clinical ...... are invasive yeast infections.
@nl
type
label
ESCMID and ECMM joint clinical ...... are invasive yeast infections.
@ast
ESCMID and ECMM joint clinical ...... are invasive yeast infections.
@en
ESCMID and ECMM joint clinical ...... are invasive yeast infections.
@nl
prefLabel
ESCMID and ECMM joint clinical ...... are invasive yeast infections.
@ast
ESCMID and ECMM joint clinical ...... are invasive yeast infections.
@en
ESCMID and ECMM joint clinical ...... are invasive yeast infections.
@nl
P2093
P50
P356
P1476
ESCMID and ECMM joint clinical ...... are invasive yeast infections.
@en
P2093
European Confederation of Medical Mycology
European Society of Clinical M ...... s Fungal Infection Study Group
O Lortholary
T Boekhout
P356
10.1111/1469-0691.12360
P478
20 Suppl 3
P577
2014-04-01T00:00:00Z